Technology Available for License

This twitter feed is meant to share the latest technology/IP available for license from institutions with track records of world-class research and innovation.

[Technology Available for License @TechnologyAvai1]

HAPPY #TTPD TO ALL IN #AUTM AND THOSE WHO MAKE THE INVENTIONS!

[Chad Riggs @lynnisjr]

Today #AUTM celebrates technology transfer professionals. December 12 is the anniversary of the Bayh-Dole Act of 1980, which enabled #technologytransfer through #universities retaining title to #inventions that can become #patented and #licensed #innovations. #IAmTechTransfer

[Technology Available for License @TechnologyAvai1]

Sign up for emails:
-St. Jude Innovators
-Technology Licensing general updates (news/available technologies)
-Regional Networking and Career Group: Graduate Students, Postdoctoral Fellows, Research Staff, etc.
-Regional Tech Transfer News and Gatherings
https://t.co/hPL5qVSbOx

[Technology Available for License @TechnologyAvai1]

The 2024 Office of Technology Licensing (OTL) Intellectual Property newsletter is now available. This issue covers an introduction to new staff, their new roles, licensing and patenting activities, the FDA approval of two hemophilia drugs.
https://t.co/7sc8tG2IRi

[Technology Available for License @TechnologyAvai1]

11/22/22, Hemgenix, was the first gene therapy for adults living with hemophilia B to be approved by the FDA

6/29/23, Roctavian was the first gene therapy for adults with severe hemophilia A to be approved by the FDA

Find out how St. Jude played a part
https://t.co/UCjBsvaEhQ

[Technology Available for License @TechnologyAvai1]

December 12, 2023 is Technology Transfer Professionals Day, the 43rd anniversary of the signing of the Bayh-Dole Act, enabling Technology Transfer! (Celebrating in Memphis,TN @5pm at Flip Side Memphis and @6:45pm at Crosstown Brewing, RSVP to [email protected])

[Technology Available for License @TechnologyAvai1]

The Office of Technology Licensing offers subscription communications for St. Jude innovators, technology licensing, researchers, and tech transfer news and gatherings. All this can be yours by subscribing.

Subscribe | St. Jude Research (https://t.co/3K5qbbUOi0)

[Technology Available for License @TechnologyAvai1]

@jayvanbavel Look for further declines after the 2007 crises cut reproduction 1/2.

[Technology Available for License @TechnologyAvai1]

Members can be from any institution, but large numbers have been from St. Jude Children’s Research Hospital, UTHSC, University of Memphis, and many graduate students from all over the country working in Memphis labs.

[Technology Available for License @TechnologyAvai1]

The Mid-South Academic Alliance will hold more lectures and networking events as “MemBioBreaks,”
to sign up for updates, please go to the form on this page: https://t.co/A2Q1rrABSx and enter your information with the box you select.

[Technology Available for License @TechnologyAvai1]

Founded in 2013, it has been a great resource through the years for working or networking opportunities, and having a good time at other events like the upcoming LifeScienceTN Beer & Biotech, LSTCON, the Scipreneur Challenge, etc.

[Technology Available for License @TechnologyAvai1]

@RepCohen @SecretaryPete We need a train from Little rock through Memphis to Nashville to Bristol to Roanoke to DC

[Chad Riggs @lynnisjr]

Because these neo-splice sites (or the cryptic exons) are not used in normal cells, therapies targeting these sites are expected to be nontoxic to normal cells and theoretically have an infinite therapeutic window.

[Chad Riggs @lynnisjr]

This genome-editing- and etiology-based strategy for cancer therapy includes an algorithm for identifying cryptic exons arising from aberrant splicing unique to cancer cells and can be applied to fusion-positive cancer patients with neo-splicing that introduced cryptic exons.

[Chad Riggs @lynnisjr]

We are seeking a partner to develop DNA Sequences Unique to Cancer cells and take it to market. https://t.co/VxG6jpVZKx

[Technology Available for License @TechnologyAvai1]

https://t.co/3jzI0YkFws

[Technology Available for License @TechnologyAvai1]

Combination DNMT3a KO and IL10 signaling (SJ-21-0018) (https://t.co/3K5qbbUgss) preserves the cell’s multipotent state during manufacturing and persistence and is available for license! More publications: DOI: 10.1126/scitranslmed.abh0272

[Technology Available for License @TechnologyAvai1]

https://t.co/Ut2uJQjDSs

[Technology Available for License @TechnologyAvai1]

NEW Publication! Method to Activate Fetal Hemoglobin Expression (SJ-20-0020) (https://t.co/3K5qbbUgss) manipulates HSCs from sickle cell disease or β-thalassemia patients to induce fetal hemoglobin and is available to license! https://t.co/8CsFUlNSQV

[Technology Available for License @TechnologyAvai1]

NEW Publication! Promoter Modification to Reduce AAV Contamination (SJ-19-0003 (https://t.co/3K5qbbUgss) has a published patent application and 2022 and 23 publications listing many advantages and is available to license!

[Chad Riggs @lynnisjr]

60 Minutes will rebroadcast an updated report on the multinational effort to help cancer-stricken children caught in the crossfire of Russia’s invasion of Ukraine, with a specific focus on the role of St. Jude. Tune in Sunday, June 25, at 6 p.m. on CBS